Home About Us Contact Us

 

Table of Content - Volume 21 Issue 3 - March 2022


 

Study of pulmonary arterial hypertension in patients of chronic kidney disease stage IV and V

 

Sohan B1*, Hamsa Manasa K2

 

1Senior Resident, Department of General Medicine, Sri Siddhartha Institute Of Medical Sciences And Research Centre, T. Begur, Nelamangala Taluk, Bangalore Rural District, Karnataka, INDIA.

2Senior Resident, Department Of Paediatrics, Adichunchanagiri Institute Of Medical Sciences, Javaranahalli Rd, Bellur, Nagamangala Taluk, Mandya District, Karnataka, INDIA.

Email: sohanb123@gmail.com,  hamsasohan24@gmail.com

 

REFERENCES

  1. Webster AC, Nagler AV, Morton RL, Masson P. Chronic kidney disease. Lancet. 2017;389(10075):1238-52.
  2. Varma PP. Prevalence of CKD in India - Where are we heading? Indian J Nephrol. 2015;25(3)133-5.
  3. White SL, Chadban SJ, Jan S, Chapman JR, Cass A. How can we achieve global equity in provision of renal replacement therapy? Bull World Health Organ 2008;86(3):229-37.
  4. Raines N, González M, Wyatt C, Kurzrok M, Pool C, Lemma T, et al. Risk factors for reduced glomerular filtration rate in a Nicaraguan community affected by Mesoamerican nephropathy. MEDICC Rev 2014;16(2):16-22.
  5. Bolignano D, Rastelli S, Agarwal R, et al. Pulmonary hypertension in CKD. Am J Kidney Dis 2013; 61: 612–622.
  6. Zlotnick DM, Axelrod DA, Chobanian MC, Friedman S, Brown J, Catherwood E, et al. Non-invasive detection of pulmonary hypertension prior to renal transplantation is a predictor of increased risk for early graft dysfunction. Nephrology Dialysis Transplantation. 2010 Mar 17;25(9):3090-6.
  7. Sicari R, Gargani L, Wiecek A et al. The use of echocardiography in observational clinical trials: the EURECA-m registry. Nephrol Dial Transplant 2012; 28: 19–23.
  8. Navaneethan SD, Roy J, Tao K, et al. Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD. Journal of the American Society of Nephrology : JASN. 2016;27(3):877–886.
  9. Mehta, Kalpana and Shirkande, AbhishekK and Bhurke, SandipP and Pajai, AtimE and Swami, RudramaniS and Jadhav, SwapnilN. (2019). Pulmonary Hypertension in Various Stages of Chronic Kidney Disease in Indian Patients. Indian Journal of Nephrology. 29. 10.4103/ijn.IJN_407_17.
  10. Mann A, Kampani G, Bansal S, Ranga S. Study of Pulmonary Arterial Hypertension in Patients of Chronic Kidney Disease Stage IV and V. J Assoc Physicians India. 2021 Oct;69(10):11-12.
  11. O'Leary JM, Assad TR, Xu M, Birdwell KA, Farber-Eger E, Wells QS, Hemnes AR, Brittain EL. Pulmonary hypertension in patients with chronic kidney disease: invasive hemodynamic etiology and outcomes. Pulm Circ. 2017 Jul-Sep;7(3):674-683.
  12. Zhang Q, Wang L, Zeng H, Lv Y, Huang Y. Epidemiology and risk factors in CKD patients with pulmonary hypertension: a retrospective study. BMC Nephrol 2018; 19:70.
  13. Suresh H, Arun BS, Moger V, Vijayalaxmi PB, Murali Mohan K. A prospective study of pulmonary hypertension in patients with chronic kidney disease: A new and pernicious complication. Indian J Nephrol 2018;28:127-34.
  14. Segall L, Nistor I, Covic A. Heart failure in patients with chronic kidney disease: a systematic integrative review. Biomed Res Int. 2014;2014:937398.
  15. Ruggenenti P, Cravedi P, Remuzzi G. Mechanisms and treatment of CKD. J Am Soc Nephrol 2012; 23: 1917–28.
  16. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kid Int Suppl 2013; 3: 1–150.